Tony Robbins and Peter Diamandis’ longevity firm Fountain Life raises $18M | TechCrunch

Date:

Eight years in the past, orthopedic surgeon Dr. William Kapp attended a medical convention that modified his skilled life. 

He had gone from a private-practice physician to co-founding an organization that constructed essential care hospitals to then promoting that firm. It gave him an curiosity for either side of healthcare: the drugs and enterprise sides, he instructed TechCrunch. 

So he went to the annual convention hosted by famed physician-scientist Dr. Daniel Kraft to find out about new tech that would enhance outcomes whereas decreasing prices. Dr. Peter Diamandis, founder and chairman of the XPRIZE Basis, was on stage that 12 months with Dr. Bob Hariri, a stem-cell pioneer and co-founder of a number of well being techs like genomics firm Human Longevity, Kapp stated. They mentioned genomics, microbiomics, and new tech that wasn’t a part of mainstream drugs.

Impressed, Kapp went again to his dwelling city of Naples, Florida, and “started a thing called Longevity Performance Center. The idea was to do early detection and then optimization of people’s health,” he stated.

In March 2020, Diamandis (pictured above) and his buddy Tony Robbins heard of Kapp’s heart and visited. That they had a stem cell startup known as Fountain Therapeutics. Dialog quickly turned towards a merger, and by October that 12 months, the 2 firms grew to become Fountain Life.

Kapp remained CEO with each Diamandis and Robbins as his co-founders and board members.

In the present day his board additionally consists of Hariri as an adviser; Todd Wanek, CEO of Ashley Furnishings Industries, as an investor; and rich Indian enterprise mogul B.Ok. Modi as an investor as effectively.

Techcrunch occasion

San Francisco
|
October 27-29, 2025

Fountain Life tells TechCrunch completely that it simply raised an $18 million Collection B, led by EOS Ventures, with participation from a lot of the current members of the board. Fountain beforehand raised an $80 million Collection A and has raised about $108 million complete, Kapp stated.

Longevity as a topic of significant research by the medical neighborhood is a brand new subject. When Kapp (pictured under) first launched his heart, “We didn’t know exactly what longevity meant,” he stated. However over the past 4 or 5 years, rather more analysis has been performed. 

The primary precept of longevity, he stated, is “don’t die of anything stupid.” Subsequently, Fountain Life’s facilities, of which there are 4 at present, have a heavy concentrate on prevention screening, in search of sicknesses and power situations at their earliest levels after they are typically asymptomatic. Blood checks and physique scans collect information on over 100 biomarkers, from liver fats to “microbiome concentrations,” he stated.

The second principal is optimization, which means enhancing these markers with scientifically validated remedies, he stated. And the third principal is “using the latest regenerative therapies under FDA trials,” to deal with sickness or obtain optimization.

Screening checks might uncover, for instance, small intestinal bacterial overgrowth (SIBO), which, left untreated, might result in sure cancers, he stated. The answer, if caught early, is to revive microbiome stability with particular, prescribed microbiotics.

Dr. William KappPicture Credit:Fountain Life

For Fountain’s members, testing is repeated each quarter or so, and sufferers can observe outcomes and ask questions of an AI-powered app known as Zori.

But it surely’s dear, Kapp admitted. A full subscription prices $30,000 a 12 months, and $10,000 will cowl simply the testing course of and AI, however not ongoing checks and medical assist.

Nonetheless, Kapp remembers two tales that instructed him this work was heading in the right direction. The spouse of a Robbins fan purchased a membership for her husband, and the checks caught early-stage, asymptomatic kidney most cancers. The husband is now cancer-free. 

When international hotelier Sam Nazarian was exploring a partnership with Fountain to put longevity facilities in luxurious lodges, Nazarian did Fountain’s checks and located a mind aneurysm. They efficiently handled it, Nazarian has publicly stated. 

Kapp says the brand new funding will enable the corporate to open extra facilities. Along with Naples, they opened amenities in Orlando, Dallas, and Westchester, New York; a middle in Houston will open in December. Facilities in Los Angeles and Miami are deliberate for Q2 of 2026. 

He hopes to resolve the affordability challenge by engaged on “clinic development” the place Fountain trains medical amenities on its methodologies. Kapp says that because the tech and experience turn out to be extra extensively out there, it will drive down prices for entry.

Fountain just isn’t the one doctor-driven longevity testing startup. Famed purposeful well being physician Mark Hyman has an organization known as Perform Health. It presents a package deal of about 160 blood checks, with follow-up checks each three to 6 months, for a $500/12 months membership (with further charges for extra blood checks). Its platform equally analyzes and tracks take a look at outcomes, though it doesn’t do full physique scans or supply direct entry to physicians.

We’re at all times trying to evolve, and by offering some perception into your perspective and suggestions into TechCrunch and our protection and occasions, you possibly can assist us! Fill out this survey to tell us how we’re doing and get the possibility to win a prize in return!

Share post:

Subscribe

Latest Article's

More like this
Related

Google Images upgrades its image-to-video function with Veo 3 | TechCrunch

Google’s newest video-generation mannequin, Veo 3, is coming to...

Fb is attempting to make ‘pokes’ occur once more | TechCrunch

Technically, the poke by no means actually left Fb....

Mark Zuckerberg sues Mark Zuckerberg | TechCrunch

Mark Zuckerberg, a chapter lawyer from Indiana, has filed...